Aberrant Methylation ofAPC, MGMT, RASSF2A, andWif-1Genes in Plasma as a Biomarker for Early Detection of Colorectal Cancer
Authors:
Open Access
- 30 September 2009
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 15 (19) , 6185-6191
Abstract
Purpose: To identify epigenetic molecular makers in plasma for the early detection of colorectal cancer. Experimental Design: We retrospectively analyzed the methylation status of 10 genes in fresh-frozen tissues and corresponding plasma samples from 243 patients with stage I and II sporadic colorectal cancer, 276 healthy individuals, and plasma from 64 colorectal adenoma patients using methylation-specific PCR. The methylation score (Mscore) was used to find molecular markers with high sensitivity and specificity. Results: Of the 243 colorectal cancer tissues, methylation was detected in 18% for p14, 34% for p16, 27% for APC, 34% for DAPK, 32% for HLTF, 21% for hMLH1, 39% for MGMT, 24% for RARβ2, 58% for RASSF2A, and 74% for Wif-1. Receiver operator characteristic curve analysis in plasma from 243 patients with cancer and 276 healthy individuals showed that the M score of any single gene had a sensitivity of APC, MGMT, RASSF2A, and Wif-1 genes had a sensitivity of 86.5% and a specificity of 92.1% when 1.6 was used as a cutoff. In this model, the M score had a positive predictive value of 90.6% and a negative predictive value of 88.8%. Conclusion: The present study suggests that tumor-specific methylation of APC, MGMT, RASSF2A, and Wif-1 genes might be a valuable biomarker in plasma for the early detection of colorectal cancer. (Clin Cancer Res 2009;15(19):6185–91)Keywords
This publication has 24 references indexed in Scilit:
- CpG island hypermethylation of E‐cadherin (CDH1) and integrin α4 is associated with recurrence of early stage esophageal squamous cell carcinomaInternational Journal of Cancer, 2008
- Profiling CpG island field methylation in both morphologically normal and neoplastic human colonic mucosaBritish Journal of Cancer, 2008
- Correlation between hypermethylation of the RASSF2A promoter and K‐ras/BRAF mutations in microsatellite‐stable colorectal cancersInternational Journal of Cancer, 2006
- Methylation enrichment pyrosequencing: combining the specificity of MSP with validation by pyrosequencingNucleic Acids Research, 2006
- CpG island methylation of genes accumulates during the adenoma progression step of the multistep pathogenesis of colorectal cancerGenes, Chromosomes and Cancer, 2006
- The Ras Effector RASSF2 Is a Novel Tumor-Suppressor Gene in Human Colorectal CancerGastroenterology, 2005
- CpG island promoter hypermethylation of a novel Ras-effector gene RASSF2A is an early event in colon carcinogenesis and correlates inversely with K-ras mutationsOncogene, 2005
- Promoter hypermethylation of tumor‐related genes in the progression of colorectal neoplasiaInternational Journal of Cancer, 2004
- Aberrant CpG island hypermethylation of multiple genes in colorectal neoplasiaLaboratory Investigation, 2004
- The power and the promise of DNA methylation markersNature Reviews Cancer, 2003